Drugmakers To Pay $300M To Settle Third-Party Payers’ Claims In Opioid MDL
CLEVELAND — Third-party payers (TPP) in the opioid multidistrict litigation moved on Aug. 30 for preliminary approval of a $300 million settlement reached with three drug manufacturers to end claims that...To view the full article, register now.
Already a subscriber? Click here to view full article